The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
WSPA Spartanburg on MSN5h
New type of non-opioid pain medication approved by FDAThe U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The savings on the 25 drugs stem from a new law that allows Medicare to haggle over the price it pays on the most popular and expensive prescription drug scripts filled by older Americans.
Copyright 2025 The Associated Press. All Rights Reserved. President Joe Biden speaks about prescription drug costs at the National Institutes of Health in Bethesda ...
Those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said. The savings will stem from a new law that allows Medicare to haggle over the price it pays on the most ...
That brings the total to 25 drugs that will have lower price tags under a historic new program that allows the government to haggle over the price Medicare pays on the most popular and expensive ...
January 17, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback